Peter Varkonyi
Overview
Explore the profile of Peter Varkonyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson A, Phipps R, Crane G, Venanzi N, Lockley W, Tredwell M, et al.
J Labelled Comp Radiopharm
. 2020 Jul;
:608-617.
PMID: 32678462
No abstract available.
2.
Ballard A, Ahmad H, Narduolo S, Rosa L, Chand N, Cosgrove D, et al.
Angew Chem Int Ed Engl
. 2017 Oct;
57(4):982-985.
PMID: 29072355
Racemization has a large impact upon the biological properties of molecules but the chemical scope of compounds with known rate constants for racemization in aqueous conditions was hitherto limited. To...
3.
Buonfiglio R, Engkvist O, Varkonyi P, Henz A, Vikeved E, Backlund A, et al.
J Chem Inf Model
. 2015 Oct;
55(11):2375-90.
PMID: 26484706
In this study, biologically relevant areas of the chemical space were analyzed using ChemGPS-NP. This application enables comparing groups of ligands within a multidimensional space based on principle components derived...
4.
Southan C, Varkonyi P, Boppana K, Jagarlapudi S, Muresan S
PLoS One
. 2013 Nov;
8(10):e77142.
PMID: 24204758
The statistics of drug development output and declining yield of approved medicines has been the subject of many recent reviews. However, assessing research productivity that feeds development is more difficult....
5.
Chen H, Carlsson L, Eriksson M, Varkonyi P, Norinder U, Nilsson I
J Chem Inf Model
. 2013 Jun;
53(6):1324-36.
PMID: 23789733
A novel methodology was developed to build Free-Wilson like local QSAR models by combining R-group signatures and the SVM algorithm. Unlike Free-Wilson analysis this method is able to make predictions...
6.
Muresan S, Petrov P, Southan C, Kjellberg M, Kogej T, Tyrchan C, et al.
Drug Discov Today
. 2011 Oct;
16(23-24):1019-30.
PMID: 22024215
The increase in drug research output from patent applications, together with the expansion of public data collections, such as ChEMBL and PubChem BioAssay, has made it essential for pharmaceutical companies...
7.
Southan C, Varkonyi P, Muresan S
J Cheminform
. 2010 Mar;
1(1):10.
PMID: 20298516
Background: Since 2004 public cheminformatic databases and their collective functionality for exploring relationships between compounds, protein sequences, literature and assay data have advanced dramatically. In parallel, commercial sources that extract...
8.
Southan C, Varkonyi P, Muresan S
Curr Top Med Chem
. 2007 Sep;
7(15):1502-8.
PMID: 17897036
The last two years have seen a dramatic expansion in public cheminformatics, as exemplified by the approximate five-fold growth of PubChem from over 50 contributing data sources. Consequently, medicinal chemists...